SCHEMBL12496003

SCHEMBL12496003

CCCCc1c(-c2cccnc2)nc(N)nc1-c1cccs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ CYP2E1 P05181 1/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ CYP2B6 P20813 1/20 0.50
▸ KDM4E B2RXH2 5/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ ADK P55263 1/20 0.43
▸ ADORA2A P29274 4/20 0.42
▸ ADORA1 P30542 3/20 0.42
▸ ADORA2B P29275 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.42
▸ HPGD P15428 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12495868 0.88 ADK (0.46) CYP3A4CYP2C9KDM4EADKADORA2A
SCHEMBL12495536 0.88 ADORA2A (0.50) CYP3A4CYP2C9CYP2A6KDM4EADORA2A
SCHEMBL12495825 0.88 ADK (0.51) CYP3A4CYP2C9KDM4EHSD17B10ADK
SCHEMBL12495847 0.87 ADORA2A (0.55) CYP3A4CYP2C9KDM4EADKADORA2A
SCHEMBL12496119 0.85 ADORA2A (0.49) CYP3A4CYP2C9CYP2A6ADORA2AADORA1
SCHEMBL12496398 0.84 ADORA2A (0.57) CYP3A4CYP2C9CYP2A6KDM4EADORA2A
SCHEMBL16223070 0.82 CYP3A4 (0.50) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL12495826 0.81 ADK (0.44) CYP3A4CYP2C9KDM4EADKADORA2A
SCHEMBL12496530 0.81 KDM4E (0.47) CYP3A4CYP2C9KDM4EADKADORA2A
SCHEMBL16223126 0.80 ADORA2A (0.40) CYP3A4CYP2C9CYP2E1CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195867-B1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I (CZ) 2019-09-04 — — EP claimed
US-8883798-B2 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2014-11-11 — — US claimed
EP-2680847-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Cr, v.v.i. (CZ) 2014-01-08 — — EP disclosed
WO-2012116666-A1 PYRIMIDINE COMPOUNDS INHIBITING THE FORMATION OF NITRIC OXIDE AND PROSTAGLANDIN E2, METHOD OF PRODUCTION THEREOF AND USE THEREOF USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, v.v.i. (CZ) 2012-09-07 — — WO disclosed
Send feedback